U.S. Markets closed

U.S. FDA advisers back authorization of Moderna COVID vaccine for ages 6-17

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

June 13 (Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc's COVID-19 vaccine for children and teens aged 6 to 17 years of age. (Reporting by Manas Mishra in Bengaluru Editing by Chris Reese)